Healthcare provider profile · identity verified

James M Mason, MD

Internal Medicine · FAIRPORT, NY · NPI 1346277050

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	499	153
Levothyroxine Sodium	Levothyroxine Sodium	489	128
Lisinopril	Lisinopril	368	100
Meloxicam	Meloxicam	307	89
Amlodipine Besylate	Amlodipine Besylate	285	86
Tamsulosin Hcl	Tamsulosin Hcl	265	75
Metoprolol Succinate	Metoprolol Succinate	259	68
Pantoprazole Sodium	Pantoprazole Sodium	256	84
Sertraline Hcl	Sertraline Hcl	242	63
Simvastatin	Simvastatin	225	63
Hydrochlorothiazide	Hydrochlorothiazide	195	54
Omeprazole	Omeprazole	189	58
Gabapentin	Gabapentin	143	37
Ozempic	Semaglutide	126	23
Zolpidem Tartrate	Zolpidem Tartrate	126	22
Irbesartan	Irbesartan	124	34
Azithromycin	Azithromycin	118	89
Rosuvastatin Calcium	Rosuvastatin Calcium	91	34
Dutasteride	Dutasteride	89	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	88	22
Furosemide	Furosemide	87	27
Metoprolol Tartrate	Metoprolol Tartrate	86	22
Trazodone Hcl	Trazodone Hcl	86	24
Prednisone	Prednisone	81	33
Losartan Potassium	Losartan Potassium	78	26
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	77	22
Metformin Hcl	Metformin Hcl	77	24
Alprazolam	Alprazolam	76	23
Metformin Hcl Er	Metformin Hcl	73	23
Fluticasone Propionate	Fluticasone Propionate	72	25
Eliquis	Apixaban	65	21
Duloxetine Hcl	Duloxetine Hcl	64	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	17
Methylprednisolone	Methylprednisolone	60	51
Allopurinol	Allopurinol	57	15
Citalopram Hbr	Citalopram Hydrobromide	57	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	56	21
Venlafaxine Hcl Er	Venlafaxine Hcl	53	12
Pravastatin Sodium	Pravastatin Sodium	52	15
Fluoxetine Hcl	Fluoxetine Hcl	50	14
Warfarin Sodium	Warfarin Sodium	50	13
Atenolol	Atenolol	48	14
Bupropion Xl	Bupropion Hcl	48	15
Famotidine	Famotidine	48	16
Oxycodone Hcl	Oxycodone Hcl	46	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	44	22
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	43	34
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	43	11
Escitalopram Oxalate	Escitalopram Oxalate	42	14
Tramadol Hcl	Tramadol Hcl	40	16
Fenofibrate	Fenofibrate	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	11
Ezetimibe	Ezetimibe	36	suppressed
Betamethasone Valerate	Betamethasone Valerate	34	16
Celecoxib	Celecoxib	34	11
Clopidogrel	Clopidogrel Bisulfate	34	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	32	13
Torsemide	Torsemide	31	12
Donepezil Hcl	Donepezil Hcl	30	15
Trulicity	Dulaglutide	30	suppressed
Glipizide Er	Glipizide	29	suppressed
Lorazepam	Lorazepam	29	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	28	28
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	28	21
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Diazepam	Diazepam	25	12
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Valsartan	Valsartan	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	24	16
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Lovastatin	Lovastatin	23	suppressed
Solifenacin Succinate	Solifenacin Succinate	23	11
Propranolol Hcl	Propranolol Hcl	22	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	22	suppressed
Mometasone Furoate	Mometasone Furoate	21	suppressed
Synthroid	Levothyroxine Sodium	21	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	20	20
Labetalol Hcl	Labetalol Hcl	20	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Butalbital-Aspirin-Caffeine	Butalbital/Aspirin/Caffeine	19	suppressed
Chlorthalidone	Chlorthalidone	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Levofloxacin	Levofloxacin	19	18
Pregabalin	Pregabalin	19	suppressed
Glimepiride	Glimepiride	18	suppressed
Carvedilol	Carvedilol	17	suppressed
Jardiance	Empagliflozin	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	16	suppressed
Estradiol	Estradiol	16	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	16	suppressed
Januvia	Sitagliptin Phosphate	16	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Cephalexin	Cephalexin	15	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Diclofenac Sodium	Diclofenac Sodium	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxycontin	Oxycodone Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Clindamycin Hcl	Clindamycin Hcl	13	suppressed
Clonazepam	Clonazepam	13	suppressed
Finasteride	Finasteride	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Megestrol Acetate	Megestrol Acetate	13	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Lagevrio (Eua)	Molnupiravir	12	12
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	12	suppressed
Tobramycin-Dexamethasone	Tobramycin/Dexamethasone	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Colchicine	Colchicine	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Ramipril	Ramipril	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error